Pancreatic Cancer Research

ResearcherTongji UniversityActive in the last 2 years

Fang Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1711-6347; OpenAlex author ID A5082831505. Sources: OpenAlex.

Their work

Papers
4 (first author 2, last author 1)
Trials
0
Grants
0
Labs led
1
Collaborators
12
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: 2 papers · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 4

  1. Effect of Stroma-directed Drugs in Combination with Chemotherapy Against Pancreatic Cancer- a Preclinical Study Co-author DOI 10.1101/2024.12.24.630138↗
  2. Association of peripheral leukocyte telomere length and its variation with pancreatic cancer and colorectal cancer risk in Chinese population. Last author DOI 10.18632/oncotarget.9536↗
  3. In vitro and in vivo targeting imaging of pancreatic cancer using a Fe3O4@SiO2 nanoprobe modified with anti-mesothelin antibody. First author DOI 10.2147/ijn.s104501↗
  4. Diagnostic value of serum carbohydrate antigen 19-9 in pancreatic cancer: a meta-analysis. First author DOI 10.1007/s13277-014-1995-9↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Peter James O'Dwyer · 1 shared paper, 2024 · strength 0.18
  2. Rong Zhou · 1 shared paper, 2024 · strength 0.18
  3. Thomas Benjamin Karasic · 1 shared paper, 2024 · strength 0.18
  4. Mark Alan Rosen · 1 shared paper, 2024 · strength 0.18
  5. Stephen Pickup · 1 shared paper, 2024 · strength 0.18
  6. Mamta Gupta · 1 shared paper, 2024 · strength 0.18
  7. Zhe Huang · 1 shared paper, 2014 · strength 0.09
  8. Rui Zhang · 1 shared paper, 2016 · strength 0.08
  9. Bingdi Chen · 1 shared paper, 2016 · strength 0.06
  10. Luguang Chen · 1 shared paper, 2016 · strength 0.06
  11. Chengwei Shao · 1 shared paper, 2016 · strength 0.06
  12. Zheng Cui · 1 shared paper, 2016 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.